GoodRx Holdings, Inc.
$1.42B- Market cap
- $1.18B
- Debt
- +$500.00M
- Cash
- −$261.82M
Capital structure 70% equity / 30% debt · EV / Revenue 1.78x · EV / EBITDA 7.54x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: GDRX stock price vs NOW: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NOW's multiple
Needs NOW P/E.
Implied fair value · at GDRX's multiple
Needs GDRX P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GDRX FY 2025 (ended Dec 31, 2025) · NOW FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 70% equity / 30% debt · EV / Revenue 1.78x · EV / EBITDA 7.54x
Capital structure 97% equity / 3% debt · EV / Revenue 11.02x · EV / EBITDA 50.26x
NOW carries the larger enterprise value at $146.31B against $1.42B; GDRX trades on the lower EV / Revenue multiple (1.78x vs 11.02x); GDRX on the lower EV / EBITDA (7.54x vs 50.26x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
GoodRx Holdings, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ServiceNow, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.81x
0.31x
Net debt / EBITDA
Leverage against operating earnings
1.26x
0.09x
Cash and equivalents
Liquid reserves on the balance sheet
$261.82M
$3.73B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Evolent Health, Inc.
GDRX vs EVH
CVS HEALTH Corp
GDRX vs CVS
Doximity, Inc.
GDRX vs DOCS
Criteo S.A.
GDRX vs CRTO
MICROSOFT CORP
GDRX vs MSFT
ADOBE INC.
GDRX vs ADBE
ORACLE CORP
GDRX vs ORCL
Salesforce, Inc.
GDRX vs CRM
INTERNATIONAL BUSINESS MACHINES CORP
GDRX vs IBM
Paycom Software, Inc.
GDRX vs PAYC
$500.00M
$3.99B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.